A combination vaccine is a mixture of two or more than two vaccines that could be administered separately, which is put into a single shot.
A combination vaccine is a mixture of two or more than two vaccines that could be administered separately, which is put into a single shot. The combination vaccine offers the same protection to children as the two vaccines administered separately, but with a few number of shots. Disease prevention and eradication of preventable diseases are eventual and instant goals of immunization and the method to achieve these goals is maintaining vaccine coverage. Vaccine coverage can be maintained by using combination vaccines, as they simplify the schedule of vaccination and reduce the number of injections required.
Read Report Overview: https://www.transparencymarketresearch.com/combination-vaccines-market.html
The development of combination vaccines for protection against multiple diseases was initiated by combining separate vaccines against tetanus, diphtheria, and pertussis into a single product. This combination of diphtheria, pertussis, and tetanus vaccines into a single product has been crucial for protection of children. Similarly, the combination of inactivated polio, hepatitis B, and Haemophilus influenzae vaccines has enabled the inclusion of these vaccines into recommended immunization schedules, by reducing the number of injections required. This has also increased the immunization compliance. However, numerous challenges are faced while developing these combinations including the abridged response to the Haemophilus influenzae vaccine when administered in combination. There is immediate need to expand the safety profile of the tetanus, diphtheria, and pertussis combination vaccine.
An important development in the field of combination vaccines was replacement of whole-cell pertussis antigens with less reactogenic acellular antigens. This paved the way for combining of tetanus, diphtheria, and acellular pertussis antigens with other routinely used vaccines such as inactivated Haemophilus influenzae vaccine, polio vaccine, and hepatitis B vaccine. Another significant combination vaccine that gives protection against more than one disease is the mumps, measles, and rubella (MMR) vaccine. A few examples of commonly used combination vaccines in children are: ProQuad, which combines MMR and varicella; Pediarix, which combines Hep B, DTaP, and IPV; Pentacel, which combines DTaP, IPV, and Hib; and Kinrix, which combines IPV and DTaP.
Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=37784
The global combination vaccines market is driven by increase in the prevalence of infectious diseases. Infectious diseases is one of the most leading causes of illnesses and deaths worldwide. In developing countries with weak health care infrastructure, influence of infectious diseases is even devastating, leading to reduced survival rates, particularly in children and hampering the economy. The increase in pediatric population is one of the primary drivers for the global combination vaccines market. With the increase in pediatric population, the demand for combination vaccines for immunization has increased, as infants are more susceptible to various infectious diseases due to their weak immune systems. Occurrence of viral infections and diseases such as polio, tetanus, diphtheria, smallpox, chickenpox, and measles has been observed to be high among children in developing countries. This is anticipated to drive the demand for combination vaccines during the forecast period. As scientists are developing and testing new vaccines to protect children from more diseases, more combination vaccines may become available in the near future. This would allow children to get additional protection with a fewer number of shots.
Request for Covid-19 Impact Analysis: https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=37784
The global combination vaccines market can be segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Asia Pacific is projected to register a high CAGR during the forecast period, due to rising pediatric population and increasing awareness about vaccination in the region. Continuous efforts by market players and national organizations to promote the use of combination vaccines would drive the market in developed countries in the near future.
Key players operating in the global combination vaccines market include GlaxoSmithKline, Merck & Co., Inc., Sanofi Aventis, Pfizer, Inc., Novartis AG, and Takeda Pharmaceutical Company Limited.
More Trending Reports by Transparency Market Research:
Aesthetics Combination Therapy Market: Combination aesthetics treatment comprises of different treatment approaches for enhancing improved and appealing appearance for consumer. It includes both negligibly intrusive and for all intents and purposes noninvasive treatment approaches. Combination treatment in aesthetics takes a shot at the rule that solitary methodology of treatment can't offer diverse preferred standpoint every treatment has while combination treatment offers best of various treatment.
Combination Antibody Therapy Market: The global combination antibody therapy market has undergone revolutionary progress in the past few years owing to continued focus on development of targeted cancer therapies that lead to fewer side effects. Targeted cancer therapies fight cancer cells with more precision, attacking only the molecules that are necessary for growth and progression of a tumor, and lead to potentially fewer side effects.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453